| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | 0.2 | 0.3 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |